Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Intel $2.55 billion senior notes offering
The senior notes are due 2031, 2034 and 2054
REV Group $289.9 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Cardinal Health $1.15 billion notes offering
The investment-grade notes are due 2029 and 2034
Kyndryl $500 million senior notes offering
We advised Kyndryl on the SEC-registered notes
Eastman Chemical $750 million notes offering
The investment-grade notes are due 2034
Xponential Fitness $37 million incremental credit facility
We advised the borrower on the facility
Prime Medicine $161 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Market
Gates Industrial $246 million secondary offering
The offering involved 20.125 million ordinary shares
Amer Sports $800 million senior secured notes offering
We advised Amer Sports on the high-yield notes offering